Two pursuits inspire me: making transformational medicines and vaccines for urgent global health challenges, and harnessing deep knowledge of human biology to drive nimble drug and vaccine development. At the Gates MRI, I am privileged to be able to combine these twin passions. As the tools at scientists' disposal become increasingly powerful, there is an urgent need to apply them with the right technical and analytical rigor to accelerate product development. It takes a closely integrated team with broad clinical, regulatory, quantitative, technical and operational expertise-like the one we’ve assembled at the Gates MRI-to get it right. I am thrilled to be part of this effort!

I come to the Institute with a background that spans academia, industry and the nonprofit sector. Most recently, I led translational research for a major industry immuno-oncology effort—an endeavor that underscored the power of translational science to transform drug discovery and development. Having worked end-to-end from discovery through registrational clinical trials, I am acutely aware of the need for robust partnerships at every stage to successfully bring lifesaving medicines and vaccines to patients. I am eager to collaborate broadly to have impact well beyond the walls of the Gates MRI.